Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pembrolizumab|DEVICE: High-intensity focused ultrasound (HIFU)
Sponsor: Patrick Dillon, MD